12
Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder S. Nirankari, MD 1,3 1 Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA 2 Jules Stein Eye Institute and Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, USA 3 Eye Consultants of Maryland, Baltimore, MD, USA The authors have no financial interest in the subject matter of this poster.

Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

Embed Size (px)

Citation preview

Page 1: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy

Authors:Paul B. Kouyoumjian, MD1

Rony R. Sayegh, MD1

Geetha G. Vedula, MD2

Verinder S. Nirankari, MD1,3

1 Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA

2 Jules Stein Eye Institute and Department of Ophthalmology, UCLA School of Medicine, Los Angeles, CA, USA

3 Eye Consultants of Maryland, Baltimore, MD, USAThe authors have no financial interest in the subject matter of this poster.

Page 2: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

Introduction• Epithelial basement membrane dystrophy (EBMD) is the most

common type of corneal dystrophy, affecting 2% of the population

• Although most patients are asymptomatic, approximately 10% of affected individuals experience corneal erosions or degradation of vision

• Erosions result from poor epithelial adhesion to the underlying basement membrane whereas visual symptoms are attributable to irregular astigmatism and abnormal tear break-up

• When conservative medical treatment fails, surgical intervention is indicated

• Surgical treatment options include simple epithelial removal, needle or Nd:YAG laser induced anterior stromal puncture, superficial keratectomy with either lamellar dissection or with diamond burr polishing, and excimer laser phototherapeutic keratectomy

• In the present study, we reviewed the outcomes of topical cocaine-assisted epithelial debridement and superficial lamellar keratectomy for the treatment of symptomatic EBMD

Page 3: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

MethodsSubjects

• Retrospective chart review of patients treated between 2002 and 2007

• Diagnosis was established by a single clinician on the basis of slit-lamp examination

• The indications for surgical intervention were decreased vision secondary to irregular astigmatism and/or recurrent corneal epithelial erosions

• 3 subgroups of patients, based on whether they presented with erosion symptoms alone, visual symptoms alone, or both, were analyzed.

Page 4: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

MethodsSurgical Technique

• All were performed by the same surgeon (VSN)

• Sterile prep and drape, insertion of eyelid speculum, topical anesthesia using tetracaine eye drops.

• Specially cut Weck-Cel sponges soaked in 4% topical cocaine are placed on the cornea for 3 to 5 minutes, loosening the epithelium.

• Epithelial debridement of almost the entire cornea is performed, leaving intact an approximately 0.5mm narrow rim of peripheral epithelium.

• Areas of subepithelial fibrosis in different parts of the cornea (central/paracentral) are removed with blunt and sharp dissection using a Paufique and/or Gill corneal knife.

• Epithelium is sent for histopathology.

• Eye is copiously irrigated with balanced salt solution.

• Therapeutic bandage contact lens (BCL) is placed, followed by topical antibiotic eye drops.

• Postoperatively, all patients were treated with topical antibiotic eye drops. Topical mid-strength steroid drops were initiated after about a week, noting that the cornea had re-epithelialized, and at which time the BCL was discontinued.

• Two cases received adjunctive treatment with mitomycin C in addition to above.

• 3 eyes of 2 patients underwent concomitant cataract extraction with PCIOL implant

Page 5: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

MethodsData Collected

• Subjective symptoms

• Perioperative and postoperative data– surgical technique

– complications (such as subepithelial haze)

– post-op treatment

– evidence of recurrence

• Pre-op visual acuity = Best Spectacle-Corrected Visual Acuity (BSCVA) at last visit prior to procedure

• Early post-op visual acuity = BSCVA closest to one month after surgery

• Last post-op visual acuity = BSCVA at most recent follow-up visit

• Pre-op and post-op corneal topography were reviewed. Surface regularity index (SRI) values were collected

• Recurrence was defined as any postoperative findings of epithelial maps, dots, or fingerprints, or symptoms consistent with recurrent erosions.

Page 6: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

ResultsPreoperative and Demographic Data

• 36 eyes of 30 patients• 12 males and 18 (60%) females• Mean patient age: 63 years (range, 42 to 89 years)• Mean follow-up: 19 months (range, 6 days to 6

years)• Subgroup analysis

– Group 1 (n=14): erosion symptoms alone– Group 2 (n=17): visual symptoms alone– Group 3 (n=5): both erosion and visual symptoms

Page 7: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

ResultsVisual Acuity

Group 1: erosion symptoms alone

Group 2: visual symptoms alone

Group 3: both erosion and visual symptoms

Page 8: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

ResultsTopographic information, i.e. Surface Regularity Index (SRI)

Page 9: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

ResultsRecurrence

• Recurrence was observed in 4 out of 36 eyes (11%)

• All belonged to the recurrent erosion subgroup (group 1)

• Recurrences occurred as early as 15 months and as late as 4 years after the procedure

– The “early” recurrence occurred in an eye treated with adjunctive mitomycin C due to preoperative suspicion of epithelial dysplasia, and which had persistent subepithelial haze

– The eye with “late” occurrence showed subtle map, dot, fingerprint changes

– Another case of recurrence was subsequently treated with PRK, almost 3 years later. The eye had previous history of anterior stromal puncture, the only one in our study

– The 4th eye with recurrence (2 years, 5 months later) warranted retreatment, which was pending at the time of this writing.

Page 10: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

Conclusions• Our study strongly suggests that the surgical technique of topical

cocaine-assisted broad epithelial debridement followed by manual superficial keratectomy is a safe, simple, and effective treatment for visual disturbances and recurrent epithelial erosions associated with EBMD.

• Amongst eyes with erosion symptoms, treatment resulted in relief of symptoms in all patients during the first 15 months, with only 4 out of 16 experiencing symptoms in the subsequent 4 ¼ years of follow-up; of these, 2 warranted retreatment.

• All eyes treated for visual symptoms secondary to EBMD alone (16) experienced a sustained improvement in vision for the duration of follow-up. Furthermore, in regards to corneal topography, this group exhibited substantial diminishment of irregular astigmatism as evidenced by the improved mean SRI.

• Other than faint subepithelial haze, which was usually transient and not visually significant, no complications occurred in any of the 36 eyes treated.

Page 11: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

Conclusions

• On review of the literature, this simple technique is at least comparable in efficacy to other well-established surgical treatments for EBMD

• Debridement of most of the epithelium as opposed to just the central 6-8 mm may result in decreased recurrence of disease

• Superficial lamellar keratectomy to remove subepithelial fibrosis likely is superior to simple epithelial debridement alone

• Cocaine may act in a similar way to alcohol, leaving behind a smooth corneal surface for regenerating epithelial cells to attach firmly

• Because of its simplicity and effectiveness, without the need for expensive instruments, we suggest this as an option for symptomatic patients

Page 12: Topical Cocaine Debridement for Epithelial Basement Membrane Dystrophy Authors: Paul B. Kouyoumjian, MD 1 Rony R. Sayegh, MD 1 Geetha G. Vedula, MD 2 Verinder

References1. Waring GO 3rd, Rodriques MM, Laibson PR. Corneal dystrophies I. Dystrophies of the

epithelium, Bowman’s layer, and stroma. Surv Ophthalmol. 1978;23:71-122.

2. Itty S, Hamilton SS, Baratz KH, Diehl NN, Maguire LJ. Outcomes of epithelial debridement for anterior basement membrane dystrophy..Am J Ophthalmol. 2007 Aug;144(2):217-221

3. Fogle JA, Kenyon KR, Stark WJ, et al. Defective epithelial adhesion in anterior corneal dystrophies. Am J Ophthalmol. 1975;79:925–940.

4. Cogan DG, Kuwabara T, Donaldson DD, et al. Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis. Arch Ophthalmol. 1974;92:470–474.

5. Reidy JJ, Paulus MP, Gona S. Recurrent erosions of the cornea: epidemiology and treatment. Cornea. 2000;19:767–771.

6. Williams R, Buckley RJ. Pathogenesis and treatment of recurrent erosion. Br J Ophthalmol. 1985;69:435– 437.

7. McLean EN, MacRae SM, Rich LF. Recurrent erosion. Treatment by anterior stromal puncture. Ophthalmology. 1986;93:784 –788.

8. Buxton JN, Constad WH. Superficial epithelial keratectomy in the treatment of epithelial basement membrane dystrophy. Ann Ophthalmol. 1987;19:92–96.

9. Orndahl MJ, Fagerholm PP. Phototherapeutic keratectomy for map-dot-fingerprint corneal dystrophy. Cornea. 1998;17:595–599.

10. Geggel HS. Successful treatment of recurrent corneal erosion with Nd:YAG anterior stromal puncture. Am J Ophthalmol. 1990;110:404–407.